Role of VEGF/VEGFR autocrine in mediating EGFR TKI resistance in non-small cell lung cancer

被引：1
|
作者：
Osude, Chike [1 ]
Lin, Leo [1 ]
Foster, Brad [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med Rockford, Rockford, IL USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2595
引用
收藏
页数：2
相关论文
共 50 条
  • [31] VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions
    Yang, Yaning
    Liu, Chengming
    Yang, Guangjian
    Xu, Haiyan
    Lei, Siyu
    Wang, Yan
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Tumor Microenvironment Remodeling Contributes to the Resistance to EGFR-TKI in EGFR-mutated Non-small Cell Lung Cancer
    Song, X.
    Zhou, C.
    Wu, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S362 - S362
  • [33] NOTCH-1 CONTRIBUTES TO EGFR-TKI ACQUIRED RESISTANCE IN NON-SMALL CELL LUNG CANCER
    Xie, M.
    Zhang, L.
    Xu, F.
    RESPIROLOGY, 2012, 17 : 89 - 89
  • [34] Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer
    Wu, Shang-Gin
    Shih, Jin-Yuan
    MOLECULAR CANCER, 2018, 17
  • [35] The reversible resistance mechanisms of second generation EGFR-TKI, Dacomitinib, in non-small cell lung cancer
    Haga, Yuya
    Tsutsumi, Yasuo
    CANCER SCIENCE, 2023, 114 : 1071 - 1071
  • [36] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance (date updated)
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S873 - S873
  • [37] Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
    Cao, Peijun
    Li, Yongwen
    Shi, Ruifeng
    Yuan, Yin
    Gong, Hao
    Zhu, Guangsheng
    Zhang, Zihe
    Chen, Chen
    Zhang, Hongbing
    Liu, Minghui
    Pan, Zhenhua
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [38] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Kyoko Otsuka
    Akito Hata
    Jumpei Takeshita
    Chiyuki Okuda
    Reiko Kaji
    Katsuhiro Masago
    Shiro Fujita
    Nobuyuki Katakami
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 835 - 841
  • [39] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Otsuka, Kyoko
    Hata, Akito
    Takeshita, Jumpei
    Okuda, Chiyuki
    Kaji, Reiko
    Masago, Katsuhiro
    Fujita, Shiro
    Katakami, Nobuyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 835 - 841
  • [40] Targeted therapy for non-small cell lung cancer: beyond EGFR and VEGF
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S220 - S221
12345